Rawalpindi: Ferozsons Laboratories Limited has announced that its Annual General Meeting (AGM) will be held on October 28, 2024, in Rawalpindi and via video-link to review the fiscal year's accomplishments and strategize for the upcoming term. This meeting marks the continuity of annual oversight and shareholder engagement in the company's governance.

The AGM, scheduled to convene in late October, will address several key items on its agenda. Initially, the meeting will confirm the minutes from last year's AGM, held on the same date in 2023. Following this procedural task, shareholders will review the company's audited financial statements for the fiscal year ending June 30, 2024. These documents include insights from the Chairperson’s Review as well as reports from both directors and auditors.

A significant point of interest for shareholders is the board's recommendation to approve a final cash dividend of 30%, which translates to Rs. 3 per share. This proposal highlights the company's financial health and its commitment to returning value to its shareholders.

Moreover, the AGM will serve as a platform to appoint auditors for the upcoming fiscal year ending June 30, 2025, and determine their remuneration. This is a crucial step in maintaining the financial transparency and accountability that stakeholders expect from a publicly listed entity.

According to information available from the Pakistan Stock Exchange (PSX), another critical agenda item includes the approval of transactions involving related parties. This point underscores the company’s adherence to corporate governance norms, ensuring that all dealings are conducted fairly and transparently.

The convergence of both physical and virtual participation methods for this AGM underscores Ferozsons Laboratories' commitment to inclusivity and adaptability, accommodating shareholders from diverse locations due to the persisting flexibility needs post-pandemic.